With significantly increased testing a key component in the battle against COVID-19, the Innovation Hub at West Virginia University is working with WVU Medicine to churn out up to 10,000 swabs weekly to meet demands for tests.
In this interview-driven series, “WVU and the Coronavirus” will examine what’s already known about COVID-19, share the latest information about the virus, explore how RNA viruses like coronaviruses work, and learn how the University community has responded to the global pandemic.
A new cohort study out of West Virginia University suggests one piece of life-support equipment—an extracorporeal membrane oxygenation machine—can be especially useful for treating some of these COVID-19 patients. But ECMO may be less helpful for COVID-19 patients who are older, who have preexisting conditions and whose heart function has deteriorated.
Breastfeeding may “rewire” babies’ brains in ways that help them acquire language, suggests a new study from the WVU Rockefeller Neuroscience Institute. Using MRI, the researchers scanned the brains of 4-to-8-year-old children and surveyed their parents about their breastfeeding history. They found that the longer a baby was breastfed, the more white matter he or she developed in language-associated parts of the brain.
Anticipating and meeting patients’ needs can take an emotional toll on nurses, even without COVID-19 as an added stressor. A new study led by Marian Reven, a Ph.D. student in the WVU School of Nursing and a registered nurse with WVU Medicine, suggests aromatherapy may reduce nurses’ feelings of stress, anxiety and fatigue on the job.
When COVID-19 started depleting stockpiles of medical gear in hotspots like New York and New Jersey, the West Virginia National Guard took notice – and reached out to experts at the John Chambers College of Business and Economics at West Virginia University to help prevent that from happening in the Mountain State.
WVU Medicine pediatric and adult allergist and immunologist Brian Peppers, D.O., Ph.D., has received Investigational New Drug approval from the U.S. Food and Drug Administration for the experimental treatment of COVID-19 using convalescent donor plasma. This is the first FDA approved Investigational New Drug trial for COVID-19 immunotherapy to include pediatric patients.
When the director of West Virginia University’s Innovation Hub heard about a massive mask making effort underway next door at the Davis College of Agriculture, Natural Resource and Design, he knew engineers in the Benjamin M. Statler College of Engineering and Natural Resources could help.